Literature DB >> 33315504

The pro-migration and anti-apoptosis effects of HMGA2 in HUVECs stimulated by hypoxia.

Zhu-Lan Cai1,2, Chen Liu1,2, Qi Yao1,2, Qing-We Xie1,2, Tong-Tong Hu1,2, Qing-Qing Wu1,2, Qi-Zhu Tang1,2.   

Abstract

High-mobility group AT-hook2 (HMGA2), serving as an architectural transcription factor, participates in plenty of biological processes. Our study is aimed at illustrating the effect of HMGA2 on hypoxia-induced HUVEC injury and the underlying mechanism. To induce hypoxia-related cell injury, HUVECs were exposed to hypoxic condition for 12-24 h. Molecular expression was determined by Western blot analysis, real-time PCR and immunofluorescence staining. Cell migration was monitored by wound healing assay and Transwell chamber assay. Cell proliferation and apoptosis were measured by MTT assay kits and TUNEL staining. In this study, we discovered that HMGA2 was upregulated in hypoxia-induced HUVECs. Overexpression of HMGA2 promoted cell migration, decreased the apoptosis ratio in response to hypoxia stimulation, while HMGA2 knockdown inhibited cell migration and accelerated apoptosis in HUVECs under hypoxic condition. Mechanistically, we found that HMGA2 induced increased expression of HIF-1α,VEGF, eNOS and AKT. eNOS knockdown significantly reduced HMGA2-mediated pro-migration effects, and AKT knockdown strikingly counteracted HMGA2-mediated anti-apoptotic effect. Hence, our data indicated that HMGA2 promoted cell migration by regulating HIF-1α/VGEF/eNOS signaling and prevented cell apoptosis by activating HIF-1α/VGEF/AKT signaling in HUVECs.

Entities:  

Keywords:  HIF-1α/VGEF/eNOS; HMGA2; HUVECs; hif-1α/VGEF/AKT; hypoxia

Mesh:

Substances:

Year:  2020        PMID: 33315504      PMCID: PMC7781619          DOI: 10.1080/15384101.2020.1850970

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  38 in total

1.  Hypoxia-responsive microRNA-101 promotes angiogenesis via heme oxygenase-1/vascular endothelial growth factor axis by targeting cullin 3.

Authors:  Ji-Hee Kim; Kwang-Soon Lee; Dong-Keon Lee; Joohwan Kim; Su-Nam Kwak; Kwon-Soo Ha; Jongseon Choe; Moo-Ho Won; Byung-Ryul Cho; Dooil Jeoung; Hansoo Lee; Young-Guen Kwon; Young-Myeong Kim
Journal:  Antioxid Redox Signal       Date:  2014-07-29       Impact factor: 8.401

Review 2.  HIF-1 at the crossroads of hypoxia, inflammation, and cancer.

Authors:  Kuppusamy Balamurugan
Journal:  Int J Cancer       Date:  2015-04-07       Impact factor: 7.396

Review 3.  The critical role of vascular endothelial growth factor in tumor angiogenesis.

Authors:  A Amini; S Masoumi Moghaddam; D L Morris; M H Pourgholami
Journal:  Curr Cancer Drug Targets       Date:  2012-01       Impact factor: 3.428

4.  Adenoviral gene transfer of activated phosphatidylinositol 3'-kinase and Akt inhibits apoptosis of hypoxic cardiomyocytes in vitro.

Authors:  T Matsui; L Li; Y Fukui; T F Franke; R J Hajjar; A Rosenzweig
Journal:  Circulation       Date:  1999-12-07       Impact factor: 29.690

Review 5.  HMGA2, microRNAs, and stem cell aging.

Authors:  Scott M Hammond; Norman E Sharpless
Journal:  Cell       Date:  2008-12-12       Impact factor: 41.582

6.  HMGA2 induces transcription factor Slug expression to promote epithelial-to-mesenchymal transition and contributes to colon cancer progression.

Authors:  Yang Li; Zhongxin Zhao; Chuanhui Xu; Zhuqing Zhou; Zhe Zhu; Tiangeng You
Journal:  Cancer Lett       Date:  2014-09-11       Impact factor: 8.679

7.  miR-663a inhibits hepatocellular carcinoma cell proliferation and invasion by targeting HMGA2.

Authors:  Weizhen Huang; Jun Li; Xiaohong Guo; Yingchu Zhao; Xia Yuan
Journal:  Biomed Pharmacother       Date:  2016-04-28       Impact factor: 6.529

8.  AT-533, a novel Hsp90 inhibitor, inhibits breast cancer growth and HIF-1α/VEGF/VEGFR-2-mediated angiogenesis in vitro and in vivo.

Authors:  Peng-Chao Zhang; Xiao Liu; Man-Mei Li; Yan-Yan Ma; Hong-Tao Sun; Xu-Yan Tian; Yan Wang; Min Liu; Liang-Shun Fu; Yi-Fei Wang; Hong-Yuan Chen; Zhong Liu
Journal:  Biochem Pharmacol       Date:  2019-12-18       Impact factor: 5.858

9.  Hypoxia-Inducible Factor 1 alpha (HIF-1α)/Vascular Endothelial Growth Factor (VEGF) Pathway Participates in Angiogenesis of Myocardial Infarction in Muscone-Treated Mice: Preliminary Study.

Authors:  Yingqiang Du; Yingbin Ge; Zhihui Xu; Nan Aa; Xin Gu; Haoyu Meng; Zhou Lin; Dongxiao Zhu; Jingjing Shi; Ruijuan Zhuang; Xueming Wu; Xiaoyan Wang; Zhijian Yang
Journal:  Med Sci Monit       Date:  2018-12-08

10.  The transcribed pseudogene RPSAP52 enhances the oncofetal HMGA2-IGF2BP2-RAS axis through LIN28B-dependent and independent let-7 inhibition.

Authors:  Cristina Oliveira-Mateos; Anaís Sánchez-Castillo; Marta Soler; Aida Obiols-Guardia; David Piñeyro; Raquel Boque-Sastre; Maria E Calleja-Cervantes; Manuel Castro de Moura; Anna Martínez-Cardús; Teresa Rubio; Joffrey Pelletier; Maria Martínez-Iniesta; David Herrero-Martín; Oscar M Tirado; Antonio Gentilella; Alberto Villanueva; Manel Esteller; Lourdes Farré; Sonia Guil
Journal:  Nat Commun       Date:  2019-09-04       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.